In reply to 'False-positive Xpert® MTB/RIF assays in previously treated patients'

Affiliations

¹ Cochrane Infectious Diseases Group, Liverpool School of Tropical Medicine, Liverpool, UK.
² Department of Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada.

Comment

Karen R Steingart et al. Int J Tuberc Lung Dis. 2015 Mar.

. 2015 Mar;19(3):366-7.

doi: 10.5588/ijtld.14.0800.

¹ Cochrane Infectious Diseases Group, Liverpool School of Tropical Medicine, Liverpool, UK.
² Department of Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada.

No abstract available

Comment in

False-positive Xpert(®) MTB/RIF assays and previous treatment.
Boyles TH, Hughes J, Cox V, Burton R, Meintjes G, Mendelson M. Boyles TH, et al. Int J Tuberc Lung Dis. 2015 Apr;19(4):495-6. doi: 10.5588/ijtld.14.0800-2. Int J Tuberc Lung Dis. 2015. PMID: 25860011 No abstract available.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N. Steingart KR, et al. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593. doi: 10.1002/14651858.CD009593.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. PMID: 23440842 Free PMC article. Updated.
False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results.
Boyles TH, Hughes J, Cox V, Burton R, Meintjes G, Mendelson M. Boyles TH, et al. Int J Tuberc Lung Dis. 2014 Jul;18(7):876-8. doi: 10.5588/ijtld.13.0853. Int J Tuberc Lung Dis. 2014. PMID: 24902569